WASHINGTON — A Washington Post article about a Food and Drug Administration review of flibanserin, a drug designed to increase female libido, misstated Hylton V. Joffe's title. Joffe is director of the FDA's division of bone, reproductive and urologic products, not director of the FDA advisory committee considering whether to approve flibanserin.
- - -
The Washington Post News Service, with Bloomberg News
Share
